AI assistant
CANN GROUP LIMITED — Board/Management Information 2018
Feb 28, 2018
64603_rns_2018-02-28_d99f1004-e20f-4345-9706-a9a928d592c5.pdf
Board/Management Information
Open in viewerOpens in your device viewer
==> picture [509 x 52] intentionally omitted <==
ASX ANNOUNCEMENT
1 MARCH 2018
CANN GROUP APPOINTS MR NEIL BELOT AS A DIRECTOR
1 March 2018 – Cann Group Limited (ASX: CAN) is pleased to announce the appointment of Mr Neil Belot as a Director of the Company.
An Appendix 3X: Initial Director’s Interest Notice follows.
For further information please contact:
Peter Crock Matthew Wright Cann Group Limited NWR Communications +61 (0) 3 9095 7088 +61 (0) 451 896 420 [email protected] [email protected]
About Cann Group
Cann Group is building a world-class business focused on breeding, cultivating and manufacturing medicinal cannabis for sale and use within Australia. The company has established research and cultivation facilities in Melbourne and is striving to provide access to medicinal cannabis for Australian patients. Cann Group has executed collaboration agreements that will enable it to establish a leading position in plant genetics, breeding, extraction, analysis and production techniques required to facilitate the supply of medicinal cannabis for a range of diseases and medical conditions. It was issued with Australia’s first medicinal cannabis research licence in February 2017, in addition to Australia’s first medicinal cannabis cultivation licence in March 2017. Aurora Cannabis Inc – one of Canada’s largest listed medicinal cannabis company – is a cornerstone investor in Cann, with a 22.9% shareholding.
Appendix 3X Initial Director’s Interest Notice
Rule 3.19A.1
Appendix 3X
Initial Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/9/2001.
Name of entity CANN GROUP LIMITED ABN 25 603 949 739
We (the entity) give ASX the following information under listing rule 3.19A.1 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | NEIL BELOT |
|---|---|
| Date of appointment | 28 FEBRUARY 2018 |
Part 1 - Director’s relevant interests in securities of which the director is the registered holder
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
Number & class of securities
N/A
- See chapter 19 for defined terms.
11/3/2002
Appendix 3X Page 1
Appendix 3X Initial Director’s Interest Notice
Part 2 – Director’s relevant interests in securities of which the director is not the registered holder
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
| Name of holder | & nature of | & nature of | Number & class of Securities |
|---|---|---|---|
| interest | |||
| Note: Provide details of the circumstances giving rise | |||
| to the relevant interest. | |||
| AURORA CANNABIS | INC | ||
| •Employee | of | Aurora | 31,956,347 fully paid ordinary shares |
| Cannabis Inc |
Part 3 – Director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Detail of contract | N/A |
|---|---|
| Nature of interest | N/A |
| Name of registered holder | N/A |
| (if issued securities) | |
| No. and class of securities to | N/A |
| which interest relates |
- See chapter 19 for defined terms.
Appendix 3X Page 2
11/3/2002